The KCNC4 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-mediated loss-of-function model in which the KCNC4 gene has been disrupted within a heterogeneous HeLa cell population. This polyclonal knockout product consists of a pool of edited cells carrying diverse KCNC4 inactivating mutations, providing a physiologically relevant tool for studying gene function without clonal selection bias. The ablation of KCNC4 eliminates expression of the Kv3.4 voltage-gated potassium channel, impairing rapid membrane repolarization and altering the electrical properties of HeLa cells. This model is ideal for researchers investigating potassium channel-dependent processes in cancer biology, ion homeostasis, and cellular excitability.
HeLa cells are a widely used human cervical adenocarcinoma line that is HPV18-positive and displays epithelial morphology. Derived from a patient with cervical cancer, HeLa cells have been instrumental in biomedical research for decades due to their robust growth, ease of transfection, and well-characterized signaling networks. The KCNC4 knockout is introduced into this established background, enabling direct comparison with parental HeLa cells to dissect Kv3.4-specific contributions to cancer cell behavior. Because HeLa cells lack classical neuronal excitability, this model uniquely focuses on non-canonical roles of potassium channels in proliferation, apoptosis, and migration.
The KCNC4 gene encodes the Kv3.4 channel, a member of the Shaw-related subfamily that mediates rapidly activating and inactivating voltage-dependent K+ efflux. This channel is regulated by membrane depolarization and second messenger systems: it is phosphorylated by PKA downstream of cAMP, and by PKC via the DAG signaling pathway, while CaMKII and the REST transcription factor modulate its expression. Kv3.4 interacts with KCNE auxiliary subunits and other Kv3 family members (KCNC1, KCNC2, KCNC3) to fine-tune channel kinetics, and associates with the actin cytoskeleton. Functionally, Kv3.4 controls membrane repolarization, action potential firing, and intracellular calcium dynamics??processes that, in cancer cells, influence cell cycle progression and motility.
In the context of HeLa cervical adenocarcinoma cells, KCNC4 knockout disrupts membrane potential regulation and ion homeostasis, providing a valuable system to explore how loss of this channel affects tumor cell physiology. Without Kv3.4, the cells’ ability to repolarize after depolarizing stimuli is compromised, potentially affecting calcium signaling and downstream events. This model enables the study of potassium channels as modulators of cancer hallmarks, including sustained proliferation, resistance to apoptosis, and metastatic capacity. It also serves as a platform for testing pharmacological agents that target ion channels, offering insights into channelopathies and the repurposing of ion channel modulators in oncology.
Primary applications include electrophysiological characterization via whole-cell patch clamp to measure ionic currents, and molecular validation through western blot and RT-qPCR to confirm KCNC4 disruption. Functional assays such as cell proliferation, migration, and drug sensitivity testing reveal the impact of Kv3.4 loss on cancer cell behavior, while immunofluorescence can assess channel localization. This polyclonal knockout population is particularly useful for screening candidate therapeutics in channelopathy research and for investigating the role of membrane potential in cancer progression. For further information or to discuss custom projects, please contact Ascent Research.
